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1. INTRODUCTION  
  Multiparticulate drug delivery systems are mainly oral dosage forms consisting 
of a multiplicity of small discrete units, each exhibiting some desired 
characteristics.Thus, multiparticulate dosage forms are pharmaceutical formulations in 
which the active pharmaceutical ingredient (API) is present as a number of small 
independent subunits. To deliver the recommended total dose, these subunits are filled 
into a sachet and encapsulated or compressed into a tablet. 
  Pellets for pharmaceutical applications are defined as spherical, free-flowing 
granules with a narrow size distribution, typically varying in diameter between 500 and 
1500 µm. Pellets are a popular multiparticulate pharmaceutical dosage form that are 
utilized for both immediate release and a number of different controlled or special release 
applications. In recent years,  great efforts have been made to develop controlled drug 
release systems via which to achieve the optimum therapeutic effect of drugs; the drug 
concentration is maintained in the therapeutic window for a period of time, thereby 
ensuring sustained therapeutic action. 
  Pellets can be produced in different ways: spraying a solution or a suspension of 
a binder and and API onto an inert core, a layering technique, spraying a melt of fats and 
waxes from the top into a cold tower (spray-congealing), forming pellets due to the 
hardening of the molten droplets, or spray-drying a solution or a suspension of the API 
forming pellets due to the evaporation of the fluid phase  spraying a binder solution into 
the whirling powder using a fluidized bed. The popular method of producing pellets is by 
the extrusion⁄spheronization technique. 
 Various pharmaceutical excipients can be used to modify the release of an API 
from pellets formulated by extrusion and spheronization. These components form a 
matrix system, which ensures appropriate liberation. Different types of polymers can be 
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used to form soluble or insoluble systems. Their properties and the interactions between 
the components influence the dissolution of the API. 
 
2. AIMS 
 Many aims are meant to ensure the preparation of matrix pellets containing 
Atenolol to improve its bioavailability: 
 The primary aim of this study was the formulation of matrix pellets containing 
Atenolol (Atn) by means of extrusion⁄spheronization with a view to increasing its 
bioavailability. Ethanol and water were used in various combinations as wetting liquid 
and their effects on the properties of the pellets formed (breaking hardness and 
dissolution). Was investigated.  Matrix former polymer was ethylcellulose (EC).  
 I set out to investigate the effects of the parameters of spheronization on the 
properties of pellets containing Atn, microcrystallinecellulose (MCC)  and EC without 
alkalizing components, and to determine the main factors which can influence the 
preparation of pellets. 
 Also to investigate the influence of the alkalizing components as pore-former and 
the wetting liquid on the formulation of pellets, and on their dissolution. 
 The fundamental aim of the present work was to study the delayed effects of 
matrix pellets coated with a gastric-resistant polymer on the release of Atn from pellets 
containing an alkalizing pore-former agent to ensure an appropriately alkaline 
micromilieu, and to improve the absorption of Atn from the intestine and therefore its 
bioavailability. 
3. STEPS OF WORKS  
In this study, the sequence that is usually applied in pharmaceutical research was 
followed and the work is divided into 5steps: selection of optimum matrix former from 
different Ethylcellulose gradients, optimum wetting liquid and operational parameters 
were determined, incorporation of alkalizing component as pore-former and to increase 
the pH at the site of Atenolol  absorption in the intestine, preparation of pellets with 
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optimum parameters and its coating and finally in vivo evaluation of bioavailability of 
Atenolol in rats. 
 
Applied materials 
The model active pharmaceutical ingredient (API) was Atenolol (At) (Ariane 
Organochem Private Ltd, Mumbai,India). Ethylcellulose (EC) (Ethocel standard 4, 10 
and 45 premium, Colorcon Ltd. Dartford, England) as pharmaceutical matrix former. 
Microcrystalline cellulose (MCC) (Vivapur 103, Rettenmaier & Söhne GmbH, 
Rosenberg, Germany) as pharmaceutical excipients structure former was. Ethanol 96% 
(Spectrum-3D, Debrecen, Hungary) and water were applied as wetting 
components.Trisodium phosphate dodecahydrate (Na3PO4*12H2O) (VWR International, 
Belgium) and disodium phosphate anhydrous (Na2HPO4) (Spektrum 3D KFT Debrecen, 
Hungary) were used as alkalizing and pore-former agents. Opadry clear (hydroxyl propyl 
methylcellulose (HPMC)) and Acryl EZE MP (Colorcon Ltd., Dartford, England) were 
utilized as coating dispersions. The latter contains methacrylic acid copolymer (Eudragit 
L100-55)® as enteric coated material and plasticizer, which are necessary during coating. 
Dimethicone (Silfar E 1049, Wacker Chemie AG, supplier: Brenntag Hungaria Kereskedelmi 
Kft, Hungary) was used as anti-foaming agent.Ariavit sunset yellow CI 15985 (Sensient Food 
Colors Hungary Kft, Hungary), Erythrosin 6560199 (Sicopharm BASF Germany)  and 
Indigo carmine E132 were used as dye. 
1. Determination of appropriate type of Ethylcellulose and granulation liquid 
Preformulation studies: water uptake 
 The uptake of liquids applied during pelletization is a very important parameter for 
the preparation of beads. The different components were tested. Table 1. 
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Table 1. Liquid uptakes of different samples, as Enslin numbers (ml/g) 
Liquid Type of powder 
EC4 EC10 EC45 MCC Atn 
Water 0.05±0.01 0.07±0.02 0.15±0.01 2.76±0.04 0.07±0.02 
Ethanol 0.25±0.02 0.29±0.02 0.61±0.01 1.88±0.14 1.09±0.05 
Water+ethanol* 0.11±0.01 0.23±0.01 0.41±0.01 2.71±0.02 0.64±0.14 
*80 ml water + 15 ml ethanol 
Preparation of pellets  
 150 g of powder mixture was prepared from 90 g of At, 30 g of MCC and 30 g of 
one or other of different ECs To obtain a uniform mixture, the powder was blended at 50 
rpm for 10 min with a Turbula mixer (W.A. Bachofen, Basel, Switzerland). 
Samples were prepared in a high-shear granulator (ProCepT 4M8 granulator, 
ProCepT nv, Zelzate, Belgium) with 95 ml of granulating liquid i.e. either 95 ml 
of water alone, or a combination of water and ethanol (80 ml/15 ml, 
respectively): 15 ml of ethanol was added before or after the addition of 80 ml 
of water, or the two were added already mixed together. 
Dissolution  
 On the basis of the liquids uptake results, pellets were prepared and tested (Table 
1).The drug release from the pellets was studied with different dissolution kinetic models 
(first-order, Higuchi, Hopfenberg, RRSBW and Langenbucher). The results showed that 
the dissolution profile of the samples could be fitted best (R2 > 0.95) with first-order 
kinetics (Eq. 1), as is expected for the dissolution of water-soluble drugs from porous 
matrices. 
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 Mt = M0(1 - e-kt) (1) 
where Mt is the amount of API released from the preparation in time t, M0 is the total 
amount of the drug, and k is the dissolution rate of the process. However, even this model 
was unable to handle the presence of a lag time, which can be observed especially in the 
case of samples prepared with ethanol. The dissolution was fitted with the Chapman-
Richards growth model (Eq. 2), which contains a shape parameter of the sigmoid-shaped 
curve (Figs 1-3), and can describe the lag time: 
 Mt = M0(1 – e-kt)c (2) 
where Mt is the amount of API released from the preparation in time t, M0 is the total 
amount of the drug, k is the dissolution rate of the process, and c is the shape parameter 
of the curve, which refers to the observed lag time of the dissolution. The dissolution 
rates and shape parameters are displayed in Table 3. 
 The results were analysed with a two-way ANOVA model. The results showed 
significant differences in the rates of dissolution of the samples. On the basis of these 
statistical differences, the samples can be divided into three groups. The highest 
dissolution rates were observed for samples S2B and S3C, those for samples S3B and 
S4C were one-tenth less, and the other samples displayed even lower dissolution rate 
constants (Table 2).  
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Table 2. Dissolution rate constants and correlation coefficients of dissolution curves 
Sample R2 values Dissolution rate 
constants Shape parameter 
S1 A 0.9968 0.04 1.35 
 B 0.9919 0.03 1.40 
 C 0.9956 0.05 1.70 
S2 A 0.9951 0.04 1.88 
 B 0.9928 0.07 3.73 
 C 0.9870 0.04 1.66 
S3 A 0.9871 0.04 2.32 
 B 0.9875 0.05 2.66 
 C 0.9929 0.07 3.74 
S4 A 0.9903 0.03 2.16 
 B 0.9968 0.04 3.10 
 C 0.9895 0.05 2.09 
Mechanical properties of pellets 
The evaluation of the process of pellet deformation involved not only determination of 
the breaking hardness, but also study of the deformation curve. The shapes of the 
breaking curves of the pellets were very similar for the samples prepared with water (Fig. 
1). They mainly comprised three phases: The first section (Fig. 1A:1) is indicative of 
elastic deformation. The pellet behaves as a Kelvin body, in which the Hooke component 
dominates. The relationship between the loading and the stress can be written as follows: 
 t = E(d - δ) (3) 
where t = the Cauchy stress tensor, E = the elasticity modulus, d = the tensor of 
deformation and δ = unit tensor. 
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A B  
Fig. 1. Deformation curves of pellets 
2. Determination of the optimum wetting liquid and operational parameter of 
pelletization of mixture.  
 During the process of extrusion⁄spheronization, determination of the main factors 
which can influence the preparation of pellets is very important. A 23 full factorial design 
was utilized to optimize the circumstances applied during pelletization. The effects of the 
parameters of spheronization on the shape of the pellets and on the dissolution were 
tested. The effects of the nature of the wetting liquid applied for pelletization on the 
parameters of the final pellets were also examined. The spheronization was carried out 
according to the factorial design (23). 
 The shapes of the pellets were very different for the different samples .Better 
results (lower values of the aspect ratio), i.e. nearly spherical products, were observed for 
the particles prepared with water.Fig.2 
A  B  
Fig. 2A and B A samples prepared.with of water⁄ethanol B water alone 
 The situation was similar for the breaking hardness of the samples (Table 3). The 
evaluation of the process of pellet deformation involved not only determination of the 
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breaking hardness, but also study of the deformation curve. The effect of the residual 
solvent on the mechanical properties of the spheres was neglected, because it was less 
than 0.5% for every sample. 
 The release of the active agent was sensitive to the nature of the kneading liquid. 
It was slower for the samples prepared with the mixture than for the samples prepared 
only with water  
Table 3. Parameters of different pellets 
Sample Aspect 
ratio 
Breaking 
hardness 
(N) 
Dissolution 
at 30 min 
(%) 
Breadth 
(µm) 
 
Length 
(µm) 
 
Water 
content 
(%) 
S1 1.54±0.28 12.00±1.80 37.55±2.54 1491.4±142.6 2303.6±484.1 0.23 
S2 1.75±0.40 13.84±2.00 31.46±5.30 1430.3±118.2 2519.1±643.3 0.27 
S3 1.61±0.32 12.20±1.76 36.91±3.72 1439.6±93.0 2326.9±502.1 0.30 
S4 1.38±0.19 11.70±1.89 51.06±2.43 1478.8±69.2 2035.8±281.9 0.23 
S5 1.33±0.16 12.68±1.19 66.70±5.64 1450.7±64.7 1928.3±274.8 0.27 
S6 1.55±0.27 15.53±1.71 67.97±2.50 1430.3±102.5 2235.3±465.1 0.40 
S7 1.49±0.25 13.55±1.69 62.27±6.81 1429.3±88.7 2138.1±339.8 0.23 
S8 1.17±0.09 12.45±1.38 54.13±5.66 1455.7±50.2 1705.3±155.9 0.23 
Evaluation of effects of factors 
 A linear approach was applied for the fitting, and the correlation coefficient (R2) 
was very good in every case (Table 4). The duration of spheronization was found to be a 
significant factor as concerns the shape of the pellets. Its negative value indicated that 
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increase of the duration enhanced the shape of the particles. The presence of ethanol in 
the wetting liquid destroyed the efficiency of the spheronization process. 
 The duration of spheronization was also significant for the breaking hardness of 
the spheres. The two other factors were similarly important. Increase of the value of each 
of the factors caused a decrease in this parameter. It is known that the shape can modify 
the breaking hardness of different systems (mainly for tablets). In the present case, there 
was no obvious connection between the relevance of the factors for shape and breaking. 
Modification of the internal structure of the spheres must therefore be responsible for this 
phenomenon. Formation of a mass with plasticity appropriate for spheronization was not 
possible with the liquid containing ethanol. Suitable wetting of MCC could not be 
achieved with the liquid with this composition. The squeezing of this liquid during 
spheronization can also be quicker, and thus the formation of an adequate structure, 
which is formed by MCC, was also disturbed. This process was enhanced by high speed 
and the duration of spheronization, which can be the explanation of the negative sign of 
these factors. 
Table 4. Values of coefficients 
Factor Coefficient for 
aspect ratio 
Coefficient for 
breaking hardness 
Coefficient for 
dissolution 
Intercept 1.4763 12.9913 50.6838 
(1) Ethanol 0.0913 -0.5588 -11.4413 
(2) Speed -0.0663 -0.5188 -0.2363 
(3) Duration -0.1238* -0.7888* 1.0313 
1 by 2 -0.0113 0.0363 4.9738 
1 by 3 0.0113 0.2013 4.0263 
2 by 3 -0.0163 0.3863 -0.1738 
R2 0.9973 0.9983 0.9731 
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3. Incorporation of alkalizing component 
 Introduction of an alkalizing component is important to increase the pH at the site 
of absorption during parallel release of Atn from the matrix pellet in the micromilieu, to 
act as pore former, and also to lead to bridge formation during drying (crystal formation). 
In this work, Na2HPO4 or Na3PO4 was used as alkalizing component. 
 The shape and surface of the pellets depend on the consistency of the mass. This 
phenomenon can influence the solubility of the components. Atn dissolves sparingly in 
water, but is soluble in alcohol. The water solubility of anhydrous Na2HPO4 and Na3PO4 
is very good, but the latter dissolves in better water. These components are insoluble in 
alcohol. It is well known that the solubility of EC in alcohol is very good. 
 For the pellet containing MCC, the binding forces can be assigned to its 
‘crystallite-gel model’, MCC particles are broken down into smaller units and even partly 
into single crystals of colloidal size during granulation and extrusion in the presence of 
water. The resulting crystallites and porous particles form a coherent gel-like network 
(with a high fraction of an insoluble solid phase) and immobilize the liquid. Over a 
particular range of water, which relates to acceptable gel strength, extrusion and 
spheronization become possible. 
 In the samples which contained Na3PO4 and the wetting liquid was water alone in 
higher amount, the alkalizing component could take up the water from the powder 
mixture. This effect improves the plasticity of the wetted mass and enhances the 
spheronization, and is therefore a pellet structure- forming parameter which can 
determine not only the shape, but also the mechanical properties. During drying, rather 
fast recrystallization of Na3PO4 resulting in strong solid bridges between the other 
particles, e.g. MCC (P2, Fig. 3). The shape of the pellets was spherical, and the surface 
was smooth with some narrow or round pores, formed during drying. It could be seen at 
higher magnification that the texture of the pellet was very compact (Fig. 4) the hardness 
of these pellets was very high. On reduction of the water amount, the degree of 
recrystallization also decreased, but in spite of this the hardness was very good.  
12 
 
    
Fig. 3. Shape of P2 pellets (SEM)                  Fig. 4. Detail of surface of sample P2 (SEM) 
4. Preparation of pellets with optimum parameter and  its coating. 
 As regards the final dosage form, the pellets containing Atn should be coated with 
intestine-soluble polymer. In accordance with the morphological observation and the 
hardness of pellets, the dissolution results indicated that the P2 pellets had the best 
composition, suitable for the development of the final dosage form. 
 For the coating process, P2 pellets were prepared again and other compositions too, 
without and with Na3PO4 (Table 5) 
Table 5. Preparation of pellets with different contents 
Samples Sample contents Coating 
Atn 
% 
Na3PO4 
% 
MCC 
% 
EC 
% 
Lactose 
% 
Water 
ml 
Opadry 
% 
Acryl-EZE 
MP 
%w/w 
Dye 
B0 25 25 30 20 - 85 3 17  
B1 25 25 30 - 20 85 - - - 
B2 25 - 30 20 25 85 - 20 - 
B3 25 - 30 - 45 85l - 20 - 
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The optimum properties of the pellets (round shape, hardness and dissolution) were 
obtained for samples B0, B2 and B3, but not for B1, which  failed in the granulation step, 
producing a very sticky plastic mass, resisting extrusion and hence  spheronization, this 
being due to the interaction that occured between the alkalizing component and lactose. 
The reason is that lactose is incompatible with many APIs. It forms Schiff bases with 
primary amino groups (present in Atn) and alkaline materials promote the decomposition. 
Subcoating materials have been widely used to prevent interactions between an API and 
an enteric coating. Our formula B0 contained a high amount of a strong alkalizing agent, 
which influenced the dissolution of the Atn earlier than required. The alkalizing 
component has very good water solubility and could dissolve in the water component of 
the coating dispersion, so that some of it could migrate into the polymer film. 
Accordingly, it was necessary to protect the core before the functional coating. The 
protective layer used was HPMC (Opadry clear) (mass 3% w/w). After drying of the 
protective layer (10 min), the coating was continued with the functional, pH-dependent 
polymer dispersion (Acryl EZE MP). There was no need for a subcoating layer for 
samples B2 and B3, because there was no alkalizing component in their compositions.  
5. In vivo evaluation of bioavailability of At  in rat.  
 Dissolution tests (in vitro) are applied as a tool with which to predict drug product 
performance in vivo. The dissolution curves in Fig. 5 demonstrate that the Atn could 
not dissolve in the gastric juice, but there was a small difference in dissolution 
profiles in the intestinal juice (Fig. 5). The total amount of Atn dissolved from sample 
B3 during 150 min. Moderate dissolution took place in the case of B2. The 
dissolution of Atn decreased slightly in the case of B0, and the total amount of Atn 
dissolved during 250-300 min. These pellets were double-coated pellets.  
Fig 5. Dissolution profile of coated pellets in fluid of pH 1.2 for first 2 h, 
 The complete release of Atn was achieved from all samples 
dissolution conditions do not fully represent the environment in the gastrointestinal 
tract, and the results can be interpreted only on an empirical basis. In the 
the solubility of the Atn was determined. Measurement of the a
these circumstances is not possible.
 The compositions of the media were 
digestion both in the stomach and in the intestines. These and other physiological and 
chemical factors can dramatically aff
small intestine, and hence the rate of absorption. To study the bioavailability of Atn in 
rats after oral administration of 6.0 mg in capsules, the plasma was collected and 
analysed by HPLC. The HPLC curves 
hence the area under the curve for sample B0 was much greater than tho
samples B2 and B3 (Fig. 
 It may be concluded that the alkalizing component enhances the absorption of Atn 
from matrix pellets prepared by an extrusion
as matrix-former. 
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CONCLUSION 
The main aim of this work was the formulation of
of extrusion⁄spheronization with a view to increasing its bioavailability.
On the basis of this study
combinations are appropriate for the formulation of pellets from powder mixtures 
containing different ECs, MCC and Atn.
 The dissolution profiles of the samples prepared with water followed first
kinetics. For the samples where the granulating liquid also contained ethanol, the 
dissolution changed, and a lag time was observable. In this case, the eth
EC, and in the drying period an EC film was formed around the drug particles, this layer 
delaying dissolution. Finally, it may be stated that the application of ethanol in the 
wetting liquid led to a decrease in the dissolution in the fi
reduction in the breaking strength of the pellets. The formation and the structure of the 
pellets differed for the sample prepared with liquid containing ethanol.
 The use of a factorial design confirmed that significant effect
only by the operational parameters, but also by the nature of the wetting liquid. Besides 
the shape, the internal structure of the pellets was changed by the optimum combination 
of factors, as indicated by the mechanical properties of th
the active agent. The presence of ethanol in the liquid caused different degrees of wetting 
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in the different components of the powder mixture. This step of our work is of help in the 
design of pellets containing an alkalizing component for increase of the bioavailability of 
the active agent. 
 In order to enhance the bioavailability of Atn from pellets, alkalizing components 
(anhydrous Na2HPO4 and Na3PO4) were used. It can be concluded that the shape 
parameters of the pellets were best when Na3PO4 was the alkalizing component. As 
concerns the wetting liquid, the higher amount of water alone resulted in pellets with the 
best compact texture, with a smooth surface and considerable hardness. MCC formed a 
coherent gel-like network and the water-soluble Na3PO4 underwent rapid 
recrystallization, resulting in strong solid bridges with the other particles. It is clear that 
the alkalizing component is able to increase the pH in the micromilieu. This effect is 
presumably manifested in the intestine too.  
 In the in vitro experiments, the dissolution release complied with the texture of 
the pellets and the effect of pH. The most uniform and total release of Atn was observed 
for the sample containing Na3PO4 and prepared with water alone, which also has a very 
good hardness and a round shape, and which is suitable for coating and further 
investigation. 
 The results of the experiments revealed that the pellets prepared by extrusion and 
spheronization were spherical and had high strength. This product was suitable for 
coating. The in vitro dissolution tests demonstrated that the alkalizing component 
promoted the dissolution of the total amount of Atn from the pellets at pH 6.8, but use of 
a protective polymer layer was necessary before the functional polymer coating. This 
double-coated pellet is an excellent product which is suitable for filling into capsules. 
 Finally, the alkalizing component enhances the absorption of Atn from the matrix 
pellet prepared by the extrusion ⁄spheronization technique. 
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FINAL CONCLUSION, NOVELY, PRACTICAL USEFULNESS 
1. To achieve optimum  properties of matrix pellets containing Atenolol and 
increasing its bioavailability: 
2. Extrusion ⁄ spheronization method is very good method to prepare pellet 
containing ethylcellulose, microcrystalline cellulose and atenolol. 
3. Ethylcellulose polymers  can be used as matrix former in preparation of pellet 
with extrusion⁄ spheronization technique. 
4. Microcrystalline cellulose is necessary for the formulation of good mass as it is 
formulation behavour. 
5. Factorial design is important to evaluate factors and parameters process during 
pellet formulation. 
6. Alkalizing components act as poreformer which improved dissolution of Atenolol 
and also increase the pH   micromilieu parallel release with atenolol.   
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